SCHEMBL25818483

SCHEMBL25818483

Clc1nc(-c2cccc(-c3ccc4c(-c5cccc6ccccc56)cccc4c3)c2)nc(-c2ccc3sc4ccccc4c3c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
ATM Q13315 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 2/20 0.34
RAB9A P51151 2/20 0.34
CYP2C19 P33261 1/20 0.34
F9 P00740 4/20 0.33
ALOX5 P09917 1/20 0.33
PIM3 Q86V86 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818386 0.94 F9 (0.38) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL25818470 0.94 KDM4E (0.35) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL25817821 0.92 PIM1 (0.36) KDM4EALDH1A1ATMHSD17B10RAB9A
SCHEMBL22274495 0.89 KDM4E (0.37) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL25818475 0.89 ALOX5 (0.42) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL22161533 0.88 HSD17B1 (0.37) KDM4EALDH1A1HSD17B10CYP1A2PIM3
SCHEMBL25818441 0.88 HSD17B1 (0.37) KDM4EALDH1A1HSD17B10CYP1A2PIM3
SCHEMBL22161406 0.88 HDAC8 (0.37) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL25818549 0.88 S1PR5 (0.37) KDM4EALDH1A1ATMHSD17B10CYP1A2
SCHEMBL25818447 0.88 F9 (0.38) KDM4EALDH1A1ATMHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 KDM4E 508/4885ALDH1A1 1010/4885ATM 2254/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 KDM4E 508/4885ALDH1A1 1010/4885ATM 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.